Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016.
Autor(es): Oster Alexandra M; Brooks John T; Stryker Jo Ellen; Kachur Rachel E; Mead Paul; Pesik Nicki T; Petersen Lyle R
Resumo: Zika virus is a mosquito-borne flavivirus primarily transmitted by Aedes aegypti mosquitoes (1,2). Infection with Zika virus is asymptomatic in an estimated 80% of cases (2,3), and when Zika virus does cause illness, symptoms are generally mild and self-limited. Recent evidence suggests a possible association between maternal Zika virus infection and adverse fetal outcomes, such as congenital microcephaly (4,5), as well as a possible association with Guillain-Barr?? syndrome. Currently, no vaccine or medication exists to prevent or treat Zika virus infection. Persons residing in or traveling to areas of active Zika virus transmission should take steps to prevent Zika virus infection through prevention of mosquito bites (http://www.cdc.gov/zika/prevention/).
Imprenta: MMWR. Morbidity and Mortality Weekly Report, v. 65, n. 5, p. 120-121, 2016
Identificador do objeto digital: 10.15585/mmwr.mm6505e1.
Descritores: Aedes aegypti - Virus ; Aedes aegypti - Sexual ; Aedes aegypti - Transmission ; Aedes aegypti - Vaccine ; Aedes aegypti - Microcephaly
Data de publicação: 2016
